CSC
IMCR icon

Caldwell Sutter Capital’s Immunocore IMCR Stock Holding History

Caldwell Sutter Capital’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.8K Buy
+625
New +$18.5K 0.01% 527

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Caldwell Sutter Capital's IMCR Position: Q2 2026 in Review

Caldwell Sutter Capital opened a new position in Immunocore (IMCR) in Q2 2026: 625 shares worth $19.8K. The stake represents 0.01% of the portfolio and ranks #527 among its holdings.

136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Caldwell Sutter Capital held 625 shares of Immunocore worth $19.8K as of Q2 2026.
  • Immunocore was a new Caldwell Sutter Capital position in Q2 2026.
  • Immunocore made up 0.01% of Caldwell Sutter Capital's portfolio in Q2 2026, its #527 holding.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Caldwell Sutter Capital's 13F filing for Q2 2026, filed 5 Aug 2026.